Sunshine Biopharma (SBFM) Stock Price, Quote & News

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 954 330 0684

Website: sunshinebiopharma.com

Address:

333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States

Luka_Brasi Jun. 27 at 11:45 PM

$SBFM These guys said they cured cancer. What happened to that?

0 · Reply

Jahubba Jun. 27 at 1:37 AM

$SBFM So Monday buyout? 700 million? Its possible! Maybe more lets hope.

1 · Reply

Masterrunner Jun. 25 at 4:58 PM

$SBFM I sold all but 1 share at 1.85$ pre-RS (a few weeks ago); which is 18.50$ today. There is nothing they can announce today or ever that will bring the SP that high. NOTHING! Trade this turd, don't hold it. NFA!

1 · Reply

MB66 Jun. 25 at 4:02 PM

$SBFM who just dumped 30K SBFMW at .05!?! 🤬😤

0 · Reply

topstockalerts Jun. 25 at 3:38 PM

$SBFM keep an eye on the dip

0 · Reply

Dailyfollower Jun. 25 at 3:01 PM

$SBFM not yet

0 · Reply

BioTuesdays Jun. 25 at 2:45 PM

$SBFM has announced the approval of its generic Anastrozole tablets of 1mg for the treatment of postmenopausal women with hormone receptor-positive breast cancer in the Canadian market. https://biotuesdays.com/2026/06/25/sunshine-receives-canadian-regulatory-approval-for-generic-anastrozole-tablets/

0 · Reply

sbn15 Jun. 25 at 2:22 PM

$SBFM

0 · Reply

2pumps1dump Jun. 25 at 2:14 PM

$SBFM 🌋

0 · Reply

MamaR Jun. 25 at 2:14 PM

$SBFM heating up! 3+

0 · Reply

Sunshine Biopharma receives Canadian approval for generic Arimidex

Jun 25, 2026, 8:00 AM EDT - 2 days ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)

2026-06-01T12:23:56.000Z - 26 days ago

Sunshine Biopharma announces Canadian approval for Rivaroxaban

Jun 1, 2026, 8:00 AM EDT - 26 days ago

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

2026-05-29T23:55:22.000Z - 4 weeks ago

Sunshine Biopharma Inc trading halted, news pending

2026-05-29T13:11:09.000Z - 4 weeks ago

Sunshine Biopharma issued U.S. patent for coronavirus treatment tech

May 29, 2026, 8:00 AM EDT - 4 weeks ago

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

2026-05-28T14:49:55.000Z - 4 weeks ago

Sunshine Biopharma announces 1-for-10 reverse split of its common stock

May 28, 2026, 9:00 AM EDT - 4 weeks ago

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

2026-05-21T11:17:11.000Z - 5 weeks ago

Sunshine announces approval of generic amoxicillin formulation for Canada

May 21, 2026, 7:00 AM EDT - 5 weeks ago

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

2026-05-19T16:21:43.000Z - 5 weeks ago

3 Penny Stocks to Watch Now, 5/19/26

AIIO GOVX

May 19, 2026, 12:05 PM EDT - 5 weeks ago

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 18, 2026, 12:15 PM EDT - 5 weeks ago

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

2026-05-18T12:55:34.000Z - 5 weeks ago

Why Is Penny Stock Sunshine Biopharma (SBFM) Up Today?

2026-05-12T21:20:04.000Z - 6 weeks ago

Sunshine Biopharma files to sell 5.825M common units

2026-04-06T12:53:12.000Z - 2 months ago

Sunshine Biopharma reports FY25 EPS ($1.44) vs. ($7.32) last year

2026-04-06T12:52:43.000Z - 2 months ago

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

Apr 6, 2026, 8:30 AM EDT - 2 months ago

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

Oct 28, 2025, 2:10 PM EDT - 8 months ago

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

2025-10-28T11:50:45.000Z - 8 months ago

Sunshine Biopharma’s Nora Pharma receives Health Canada approval for domperidone

Oct 28, 2025, 7:45 AM EDT - 8 months ago

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

2025-10-20T11:50:37.000Z - 8 months ago

Sunshine Biopharma announces commercial launch of doxycycline in Canada

Oct 20, 2025, 7:45 AM EDT - 8 months ago

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

2025-10-16T11:50:20.000Z - 9 months ago

Sunshine Biopharma’s Nora Pharma launches pravastatin

Oct 16, 2025, 7:45 AM EDT - 9 months ago

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

Oct 14, 2025, 10:45 AM EDT - 9 months ago

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

Oct 14, 2025, 8:50 AM EDT - 9 months ago

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

2025-10-14T11:20:53.000Z - 9 months ago

Sunshine Biopharma allocates $5M for investment in bitcoin

Oct 14, 2025, 7:00 AM EDT - 9 months ago

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

2025-10-09T12:26:07.000Z - 9 months ago

Sunshine Biopharma, University of Arizona develop series of protease inhibitors

Oct 9, 2025, 8:00 AM EDT - 9 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

2025-07-02T12:26:57.000Z - 1 year ago

Sunshine Biopharma’s Nora Pharma launches NIOPEG

Jul 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

Jun 11, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

May 15, 2025, 4:15 PM EDT - 1 year ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

May 6, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

Apr 21, 2025, 8:30 AM EDT - 1 year ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

Apr 3, 2025, 10:50 AM EDT - 1 year ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Apr 2, 2025, 1:20 PM EDT - 1 year ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

Apr 1, 2025, 5:09 PM EDT - 1 year ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Jan 21, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Jan 15, 2025, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

Dec 9, 2024, 7:30 AM EST - 1 year ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 2, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Nov 6, 2024, 8:00 AM EST - 1 year ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Aug 26, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Aug 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Aug 6, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Announces Reverse Stock Split

Apr 19, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Apr 1, 2024, 8:00 AM EDT - 2 years ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Feb 15, 2024, 9:15 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Feb 13, 2024, 9:00 AM EST - 2 years ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Dec 4, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Moves Principal Office to New York City

Nov 13, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Sep 21, 2023, 9:05 PM EDT - 3 years ago

Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance

Aug 11, 2023, 8:30 AM EDT - 3 years ago

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

May 16, 2023, 2:15 PM EDT - 3 years ago

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

May 16, 2023, 9:58 AM EDT - 3 years ago

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

May 12, 2023, 8:00 AM EDT - 3 years ago

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

May 11, 2023, 9:00 AM EDT - 3 years ago

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

Luka_Brasi Jun. 27 at 11:45 PM

$SBFM These guys said they cured cancer. What happened to that?

0 · Reply

Jahubba Jun. 27 at 1:37 AM

$SBFM So Monday buyout? 700 million? Its possible! Maybe more lets hope.

1 · Reply

Masterrunner Jun. 25 at 4:58 PM

1 · Reply

MB66 Jun. 25 at 4:02 PM

$SBFM who just dumped 30K SBFMW at .05!?! 🤬😤

0 · Reply

topstockalerts Jun. 25 at 3:38 PM

$SBFM keep an eye on the dip

0 · Reply

Dailyfollower Jun. 25 at 3:01 PM

$SBFM not yet

0 · Reply

BioTuesdays Jun. 25 at 2:45 PM

0 · Reply

sbn15 Jun. 25 at 2:22 PM

$SBFM

0 · Reply

2pumps1dump Jun. 25 at 2:14 PM

$SBFM 🌋

0 · Reply

MamaR Jun. 25 at 2:14 PM

$SBFM heating up! 3+

0 · Reply

ProfessorDman1 Jun. 25 at 2:13 PM

$SBFM bingo .. told you gave you this 2.02-2.04 buy idea this morning

0 · Reply

topstockalerts Jun. 25 at 2:10 PM

$SBFM waking up

0 · Reply

24DV4NC3D Jun. 25 at 1:41 PM

$SBFM ⚡️WHAT DID I SAY?!⚡️ STOCK OF THE DAY - VOLUME >>> GREAT SETUP <<< >>>>> #LISTEN! <<<<< 🎯 XXX% ON TAP >> CONTINUATION LIKELY! << >>>>>>> LISTEN! <<<<<<<

0 · Reply

topstockalerts Jun. 25 at 1:41 PM

$SBFM keep an eye on it

0 · Reply

ProfessorDman1 Jun. 25 at 1:39 PM

$SBFM they loading … watch this one goes boom soon 🔜 $ILLR 300% ✅

0 · Reply

ProfessorDman1 Jun. 25 at 1:26 PM

$AZI $KUST $MIMI $NEXR $SBFM 2.50 > $3+ nice buying opportunity here sub 2.20

0 · Reply

FatCatFenix Jun. 25 at 1:15 PM

$SBFM ohh yay! another BS generic drug PR where these “bulls” try and convince themselves its the holy grail of all drugs and the stock will rise like the second coming. 😂 yall remember Niopeg 😜 There will be tiny pump, to liquidate the warrants.. expect more PRs and sell on halt day! This needs to hit over 20$ just to match the last tiny pre-rs pump 🤣 and 2000$ just to make those who bought in 2024 whole again.

0 · Reply

StocHunter Jun. 25 at 1:04 PM

$SBFM

0 · Reply

ProfessorDman1 Jun. 25 at 12:54 PM

$SBFM bottomed chart low 2s here with morning PR oversold as well … recent RS and low floater should be over $4 buying opportunity here $MIMI $KUST $NEXR $AZI

0 · Reply

contra7 Jun. 25 at 12:29 PM

$SBFM “Value Surfacing” ahead of disclosure common before M&A announcements

1 · Reply

ProfessorDman1 Jun. 25 at 12:22 PM

$SBFM took few low 2s and bottomed chart right now … news out this morning as well .. recent post RS has a history of running .. low floater too $KUST $MIMI ✅✅

0 · Reply

2pumps1dump Jun. 25 at 12:21 PM

$SBFM nice news, needs volume 🔊

0 · Reply

Market Cap	1.09M
Revenue (ttm)	36.31M
Net Income (ttm)	-5.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-16.47%
Debt to Equity Ratio	0.00

Volume	70,000
Avg Vol	2,008,310
Day's Range	N/A - N/A
Shares Out	501,000.00
Stochastic %K	53%
Beta	1.12
Analysts	Sell
Price Target	$56.00